Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Cardiomyopathy Clinical Trials
Cardiomyopathy clinical trials are recruiting across 76 cities. Here are the cities with the most active studies:
Cardiomyopathy Trial Phases
45 research organizations are sponsoring cardiomyopathy trials.
About Cardiomyopathy
Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated, hypertrophic, and restrictive cardiomyopathy. Treatment depends on the type and may include medications, devices, or heart transplant.
Clinical trials are advancing new treatments for cardiomyopathy. Currently, 61 studies are recruiting a combined 10,066,338 participants across the United States. Research is being conducted by 45 organizations including Mayo Clinic, Montefiore Medical Center, Alnylam Pharmaceuticals and 42 others.
2026 Cardiomyopathy Research Landscape
As of July 2026, the cardiomyopathy clinical trial landscape includes 61 actively recruiting studies across 76 cities in the United States. These studies are collectively seeking 10,066,338 participants, with an average enrollment target of 165,022 per study.
The research spans multiple phases of development: 13 studies are in PHASE1, 11 studies are in PHASE2, 9 studies are in NA, 7 studies are in PHASE3, 2 studies are in PHASE4, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some cardiomyopathy treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 45 different organizations, including Mayo Clinic, Montefiore Medical Center, Alnylam Pharmaceuticals, University of Chicago, Bristol-Myers Squibb, and 40 others. The large number of sponsors reflects significant research interest and investment in cardiomyopathy treatment advancement.
Geographically, cardiomyopathy trials are most concentrated in Boston, Massachusetts (15 trials); Los Angeles, California (12 trials); Rochester, Minnesota (10 trials); San Francisco, California (10 trials); Washington D.C., District of Columbia (8 trials) and 7 other cities.
Featured Cardiomyopathy Studies
Highlighted recruiting studies for cardiomyopathy, selected by enrollment size and research scope.
A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
The purpose of this study is to deploy and evaluate informational AI-Echo algorithms that assist echo clinicians in interpreting core echocardiographic parameters (e.g., LV/RV size and function, valvular disease severity) and stratifying disease progression risk. The primary outcome is clinician usability, interpretive consistency, and workflow integration. Second, we will conduct a pragmatic, ste...
Cardiovascular Multimodality Imaging Study
Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, advanced cardiac imaging has become a vital tool in diagnosis and risk stratification of cardiovascul...
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
The purpose of this study is to: * Describe the clinical characteristics of adult patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM) treated with vutrisiran in routine clinical care * Describe treatment patterns of adult patients with ATTR-CM treated with vutrisiran in routine clinical care * Assess health-related quality of life (HRQOL) in adult patients with ATTR-CM ...
Frequently Asked Questions About Cardiomyopathy Clinical Trials
Are there cardiomyopathy clinical trials near me?
Yes, there are 61 cardiomyopathy clinical trials currently recruiting across 76+ cities in the United States, including Boston, Massachusetts; Los Angeles, California; Rochester, Minnesota. Browse the studies above to find one at a location convenient for you.
How do I join a cardiomyopathy clinical trial?
To join a cardiomyopathy clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are cardiomyopathy clinical trials free?
Yes, participation in cardiomyopathy clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of cardiomyopathy treatments are being studied?
Current cardiomyopathy clinical trials are testing a range of approaches across PHASE1 (13 studies), PHASE2 (11 studies), NA (9 studies), PHASE3 (7 studies), PHASE4 (2 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 45 research organizations.
Is it safe to participate in cardiomyopathy clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov